Sanofi, the maker of Zantac, began pulling the heartburn drug from shelves recently after the Food and Drug Administration announced that it would investigate a carcinogen detected in the drug. 
According to USA Today, the FDA announced that it had discovered NDMA (nitrosodimethlamine) in the drug and its generic versions. Because of this, the agency said it would begin evaluating the possible risks to the public.
Following the FDA discovery, Sanofi announced that it would voluntarily recall products in the U.S. and Canada. The agency allegedly began looking into the drug after a small Connecticut pharmacy tested versions and found that they contained NDMA levels significantly higher than the FDA’s recommended daily limits.
For more information on the recall, you can click on the source link below. The FDA allegedly conducted its own testing, and while it did not find the same levels of NDMA as the pharmacy, it did find levels high enough to warrant further investigation.
“Due to inconsistencies in preliminary test results of the active ingredient used in the U.S. and Canadian products, Sanofi has made the decision to conduct the voluntary recall in the U.S. and Canada as the investigation continues,” the drug company said in a statement, according to USA Today.
Have You Been Harmed by a Dangerous Drug?
If you have been injured by a recalled or defective drug, contact our Central Texas personal injury attorneys today. Our lawyers can investigate your purchase or prescription history to determine if your drug was involved in a recall or has caused other people harm.
We will fight drug manufacturers to help provide you with damages for your injuries, which can help you recover financially. This news about Zantac is certainly alarming, as it is an incredibly popular drug. We will continue to monitor drug recalls and keep you up to date on any news.
We are the personal injury law experts of Central Texas. Contact us today. For a free discussion about your case, call 1-(800)-460-0606.
